Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
68.26
-3.19 (-4.46%)
At close: Apr 1, 2025, 4:00 PM
68.01
-0.25 (-0.37%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Soleno Therapeutics stock have an average target of 95.75, with a low estimate of 73 and a high estimate of 123. The average target predicts an increase of 40.27% from the current stock price of 68.26.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 | 5 |
Buy | 4 | 4 | 4 | 4 | 4 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 6 | 6 | 6 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $100 | Strong Buy | Maintains | $70 → $100 | +46.50% | Mar 31, 2025 |
Stifel | Stifel | Strong Buy Maintains $74 → $108 | Strong Buy | Maintains | $74 → $108 | +58.22% | Mar 28, 2025 |
Guggenheim | Guggenheim | Strong Buy Maintains $70 → $81 | Strong Buy | Maintains | $70 → $81 | +18.66% | Mar 28, 2025 |
Laidlaw & Co. | Laidlaw & Co. | Strong Buy Maintains $75 → $105 | Strong Buy | Maintains | $75 → $105 | +53.82% | Mar 27, 2025 |
Baird | Baird | Buy Maintains $72 → $102 | Buy | Maintains | $72 → $102 | +49.43% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.80
from -4.38
EPS Next Year
-0.69
from -2.80
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 77.2M | 283.5M | 497.7M |
Avg | 33.3M | 194.4M | 330.9M |
Low | 6.8M | 34.3M | 61.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 750.6% | 156.1% |
Avg | - | 483.1% | 70.2% |
Low | - | 2.9% | -68.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.05 | 0.97 | 3.89 |
Avg | -2.80 | -0.69 | 2.47 |
Low | -5.51 | -4.04 | -1.39 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.